Erica Dearstyne

Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.

Scott S. Graves, Erica Dearstyne, Yukang Lin et al. · PubMed · 2003 · 53 citations

Medicine, Oncology, Pharmacology +17

Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall Survival

Emmanuel S. Antonarakis, Eric J. Small, Daniel P. Petrylak et al. · Clinical Cancer Research · 2018 · 40 citations · Full text

Medicine, Immunology, Oncology +17

Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced decrease in anti-CD3-activated CD4+ T cells: the roles of apoptosis, Fas, and TNF

Erica Dearstyne, Nancy I. Kerkvliet · Toxicology · 2002 · 34 citations

Life Sciences, Immunology, Toxicology +12

CTL Hyporesponsiveness Induced by 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Role of Cytokines and Apoptosis

Rodney A. Prell, Erica Dearstyne, Linda G. Steppan et al. · Toxicology and Applied Pharmacology · 2000 · 21 citations

Life Sciences, Cancer Biology, Toxicology +12